A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned

作者：Szu Shousun C^*; Hunt Steven; Xie Guilin; Robbins John B; Schneerson Rachel; Gupta Rajesh K; Zhao Zhigang; Tan Xiaomei

来源：Vaccine, 2013, 31(15): 1970-1974.

DOI：10.1016/j.vaccine.2013.02.006

• Typhoid
• Capsule
• Vi
• Antibody
• Reference
• Serum
• Standard

Recent data showing the high incidence of typhoid fever in young children, the demonstration of safety and efficacy of a Vi conjugate for this age group, the safety and similar immunogenicity in infants when administrated concurrently with EPI vaccines, together with the interests of manufacturers and investigators in studying such conjugate vaccines prompted us to prepare a human IgG anti-Vi standard to facilitate this work. Volunteers were injected with an investigational Vi-recombinant Pseudomonas aeruginosa exoprotein A (Vi-rEPA) conjugate vaccine. Plasmas with the highest levels of IgG anti-Vi were pooled. The IgG anti-Vi content of this preparation, assayed by precipitin analysis with purified Vi, was 33 mu g/ml. Accordingly, the estimated IgG anti-Vi protective level of 3.5 ELISA unit/ml, derived from our efficacy trial of Vi-rEPA in 2-5 years old children, is equivalent to 4.3 mu g/ml. This reagent is suitable for comparison of immune response of Vi conjugate vaccines or for other purposes requiring anti-Vi measurement. Published by Elsevier Ltd.

• 出版日期2013-4-8